Ultra-Hypofractionated Radiotherapy Plus Boost for T1-2 Breast Cancer Patients: Early Results of a Prospective Study Based on the Fast-Forward Scheme
The present study highlights the safety of a hypofractionated RT boost to the tumor bed after ultra-hypofractionated whole-breast RT. No clear evidence exists to date regarding the superiority of delivering a tumor bed boost after ultra-hypofractionated RT or the specific patient subgroups to which a boost should be prescribed.
Authors
- Efstathios Efstathopoulos (ORCID: https://orcid.org/0000-0003-2747-3353)
- Nikolaos Kelekis (ORCID: https://orcid.org/0000-0002-8958-4668)
- Efrosyni Kypraiou
- Ioannis M. Koukourakis (ORCID: https://orcid.org/0000-0003-3143-8585)
- George Patatoukas
- Nikolaos Kollaros
- Anna Zygogianni
- Vassilis Kouloulias
- Kalliopi Platoni
Institutions
- National and Kapodistrian University of Athens (GR)
Publication Details
- Journal
- European Journal of Breast Health
- Published
- 2025-12-25
- DOI
- https://doi.org/10.4274/ejbh.galenos.2025.2025-8-1
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00